M&A Markets Blog: January 30 2018
As promised on January 2, we are reviewing the M&A Contenders List. It is a shame that the closed shop of journalism (and indeed finance) is operational here for this website, otherwise more people would be aware of this website. The usual protocol is that a source is cited if it contains novel / scoop information. One wonders why this is not happening for Zakmir.com?
But hopefully one or two people have found the information useful. I have annotated each situation with a brief note describing where we are now. All comments refer to what has happened SINCE the beginning of the year update here. As is evident, the results have been quite good, with four clear wins.
UK
Capital & Counties (CAPC) – A bid situation according to The Sunday Times
Shire (SHP) – waiting, although low share price lessens timeframe of developments. This is because for January there have been more biotech deals done than ever before.
Vectura (VEC) – volatile, but still in play as a contender.
Europe
Temenos Group (TEMN) – Softbank looking, Sunday Times.
US
Blackhawk Network (HAWK) – bid received.
Bunge (BG) – Subsequently mentioned in WSJ, another approach from “another party” not Glencore, which was ADM
Global Blood Therapeutics (GBT) – up 50% on drug approval. Bid yet to come?
A new M&A Contenders List will be issued shortly, so watch this space.
